Amyotrophic Lateral Sclerosis Assn

EIN: 133271855

Accepts Applications

Total Assets

$127.9M

Key Financial Metrics (2024)

Total Giving

$15.1M

Number of Grants

159

Median Grant

$49K

Grant Range

$7K - $750K

Historical Giving Trends

Year	Assets	Total Giving	# Grants	Median Grant
2024	$127.9M	$15.1M	159	$49K
2023	$94.4M	$14.9M	219	$25K

Recent Grant Recipients

PROJENX INC

CLINICAL TRIAL AWARD

• 2024

$750K

UNIVERSITY OF KANSAS MEDICAL CENTER RESEARCH INSTITUTE INC

TRIAL CAPACITY PROGRAM; CLINICAL TRIAL AWARD

• 2024

$600K

AQUILUS PHARMACEUTICALS INC

CLINICAL TRIAL AWARD

• 2024

$500K

UNIVERSITY OF MIAMI

ANNUAL GRANT PAYMENT FY24 CENTER OF EXCELLENCE/RESEARCH; BITNER PLANTE QUARTERLY GRANT; ADDITIONAL QUARTERLY GRANT FUNDING

• 2024

$455K

MAYO CLINIC ARIZONA

SEED GRANTS PROGRAM; TRIAL CAPACITY PROGRAM; QUALITY OF CARE PROGRAM

• 2024

$400K

UNIVERSITY OF FLORIDA

CLINICAL TRIAL AWARD

• 2024

$390K

BAYLOR COLLEGE OF MEDICINE

TRIAL CAPACITY PROGRAM; QUALITY OF CARE PROGRAM

• 2024

$350K

REGENTS OF THE UNIVERSITY OF MICHIGAN

SEED GRANTS PROGRAM; TRIAL CAPACITY PROGRAM; PREVENTION PROGRAM; INVESTIGATOR INITIATED AWARD MULTI YEAR

• 2024

$350K

THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK

PREVENTION PROGRAM; TRIAL CAPACITY PROGRAM; INVESTIGATOR INITIATED AWARD MULTI YEAR; POST DOCTORAL FELLOWSHIP

• 2024

$349K

UNIVERSITY OF MIAMI

PREVENTION PROGRAM

• 2024

$344K

Quick Facts

Location

Virginia

Return Type

990

Most Recent Filing

2024

Annual Expenses

$98.8M

Giving Rate

11.8% of assets

Application Policy

Accepts Applications

Yes - Open to Applications